Topic - Sanofi-Aventis

avatar
Biosciences, Finance

Eli Lilly Sleeps Better with Buyout

Drug giant agrees to acquire sleep-aid developer Hypnion.
avatar
Biosciences

Inhale Your Medicine

The greatest thing since insulin? Inhaled insulin.
avatar
Biosciences

Sanofi-Aventis Profit Slips 12%

Drug maker hit hard in Q3 as rival launches generic blood thinner.
avatar
Biosciences

Bristol-Myers Takes a Hit

Generic competition with Plavix squashes earnings by 65 percent.
avatar
Biosciences

ImmunoGen Lands Licensing Deal

Sanofi-Aventis will pay licensing fees for access to technology used for antibodies.
avatar
Biosciences

Saving Plavix from Generic Hands

Bristol-Myers tries to slow the process of its best-selling drug going generic.
avatar
Biosciences

Gates: Help Women Stop AIDS

Bill and Melinda Gates call for better tools to help women.
avatar
Biosciences

Report: Raid at Bristol-Myers

FBI agents raided the office of the company’s CEO, according to a report.
avatar
Biosciences

Drugs & Devices: Higher Ante

Barr raises Pliva offer; Cephalon’s Fentora close to approval; Ketek gets a warning.
avatar
Biosciences

Drug Firms Stop Malaria Drug

Indian companies comply with WHO directive to phase out single-drug artemisinin.
avatar
Biosciences

Plavix Patent Suit Settled

Bristol-Myers Squibb and Sanofi-Aventis reach agreement with Apotex on infringement claims.
avatar
General news, Biosciences

Dr. Reddy’s Buys Betapharm

Indian pharma company outbids its rival Ranbaxy and others in a $570-million deal.
avatar
Biosciences

Pfizer Jumps Gun on Exubera

Drug maker receives long-awaited FDA nod on its Exubera insulin inhalant, but leaks word a little early.
avatar
Biosciences

Serono in $15B Takeover Talks

Biotech company is negotiating its acquisition with Novartis, GlaxoSmithKline, Sanofi-Aventis, and Pfizer.
avatar
Communications

TechSpin: Google Übernet

Search titan builds massive space inside communications nerve center; Vonage seeks sale; BT starts new life; drug makers launch clinical trials site.
avatar
General news, Biosciences

U.S. Builds Bird Flu Stockpile

U.S. government awards over $100 million to Sanofi Pasteur and GlaxoSmithKline to develop drugs against possible pandemic.
avatar
Biosciences

Sanofi Climbs on Old Results

A new publication of breast cancer data announced in 2003 pushes Sanofi-Aventis' shares up 2.3 percent.
avatar
General news, Biosciences

Copaxone Sales Hit Record

Sales of Teva’s leading multiple sclerosis drug hit a record $291 million in the second quarter.
avatar
Biosciences

Drugs & Devices Report

Silicone testimony gets underway; Elan is probed by the SEC; toxic combos are investigated; Sanofi-Aventis’ sleep aid is delayed; and FDA approvals are listed.
avatar
Biosciences

Drugs & Devices

Advisory panel recommends FDA approval for whooping cough vaccines; genetics and insurance still don’t mix; Medtronic loses patent case; FDA gets more reports of side effects; Viasys makes a pulmonary-market move; Baxter ‘corrects’ itself; the FDA clears ANS and Boston Scientific.
Page 1 of 2
1 2 >